Cargando…
Evaluating the Effectiveness of Apixaban Additional Risk Minimisation Measures Using Surveys in Europe
BACKGROUND: Apixaban (ELIQUIS(®)) is a direct oral anticoagulant authorised for multiple indications in the European Economic Area (EEA). Additional risk minimisation measures (aRMMs) to address the risk of bleeding include educational materials comprising a Prescriber Guide and Patient Alert Card....
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979585/ https://www.ncbi.nlm.nih.gov/pubmed/33660230 http://dx.doi.org/10.1007/s40290-021-00380-1 |